Although taking potent statins may increase blood sugar levels for some people, their benefits may outweigh risks when managing cholesterol.

Least-fit individuals on high-intensity statins had a 21% higher risk of diabetes compared with the least-fit individuals on ...

Ocular manifestations like xanthelasma and arcus corneae are early indicators of high cholesterol and increased ...

The Family Heart Foundation, a leading research and advocacy organization, published new research in the American Journal of ...

Low LDL-C is strongly linked to increased type 2 diabetes risk, independent of statins, suggesting biomarker potential.

Very low bad (LDL) cholesterol may increase future risk of diabetes even in people who do not take statins. LDL-C could be a warning sign for metabolic imbalance.

Variants that lower LDL cholesterol through pathways such as HMGCR and NPC1L1 are linked to a higher risk of type 2 diabetes. People with familial hypercholesterolaemia, who have very high LDL ...

New review shows statins remain first-line therapy in MASLD, while PCSK9 inhibitors offer potential but require more evidence. Learn more about evolving treatment guidance.

Beren Therapeutics P.B.C.®, a Public Benefit Corporation and parent company of Mandos LLC®, today announced that Mandos received Breakthrough Therapy Designation (BTD) from the U.S. Food and Drug ...

Early CRISPR treatment showed major cholesterol reduction in just two weeks * High-dose therapy led to about a fifty percent ...

Researchers show statins force open RyR1 calcium channels in muscle cells, revealing the cause of muscle damage and paths to ...

Cardiologist and Men's Health advisory board member Christopher Kelly, MD, says this treatment is "approaching magic" for people with high cholesterol. "It’s definitely where the future of medicine is ...